Loading clinical trials...
Loading clinical trials...
Diagnostic Accuracy of Dynamic Susceptibility Contrast (DSC) Perfusion MRI to Determine Radiation Necrosis Versus Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery
Conditions
Interventions
Dynamic Susceptibility Contrast-MRI (DSC-MRI)
Magnetic Resonance Imaging (MRI)
Locations
2
United States
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States
Start Date
November 28, 2018
Primary Completion Date
May 28, 2019
Completion Date
May 28, 2019
Last Updated
January 11, 2024
NCT04988009
NCT03270059
NCT03741673
NCT03184038
NCT04114981
NCT02910700
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions